Maharashtra’ Food and Drug Administration has ordered an FIR against eCommerce giant Snapdeal founders Kunal Bahl and other directors for allegedly selling prescription based drugs on the website. The FDA had asked the company to furnish documents pertaining to the distribution and sale
Recent Posts
- THE ILLUSION OF TRUCE: Decoding the U.S.–Iran War and the Myth of a Quick End
- The $1.1 Billion Paradox: Inside Emcure’s High-Stakes Legal Warfare, US FDA Scrutiny, and Leadership Exodus
- Why Healthcare in India Needs Urgent Attention?
- Beaufond PLC Eyes Dutch Pharma Alliance to Drive Oncology & Anti‑Malarial API Growth
- Trusted by His Tribe, Distrusted by the Nation: The Trump Paradox










